Monday, 19 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

19:26 IST BSE
AcquisitionITC Hotels Ltd ITCHOTELS

ITC Hotels Acquisition Worth ₹175 Cr

ITC Hotels acquired 100% of Zuri Hotels and Resorts for ₹175 Crore. The move adds a luxury Kerala resort to its portfolio to strengthen hospitality operations.

Value
₹175.0 Cr
19:22 IST NSE
PartnershipYudiz Solutions Ltd YUDIZ

Yudiz Solutions Partnership

Yudiz Solutions partnered with MetaShot to launch the world's first smart pickleball game. This strategic alliance targets the global motion gaming market starting Q3 FY26.

Execution
Launch scheduled for Q3 FY26
19:21 IST BSE
Merger & RestructuringGujarat Themis Biosyn Ltd GUJTHEM

Gujarat Themis Biosyn Merger & Restructuring Worth ₹0.61 Cr

Gujarat Themis Biosyn incorporated a wholly owned subsidiary in Japan named Themis Biosyn Japan Limited. This expansion strengthens the company's international pharmaceutical business footprint.

Value
₹0.61 Cr
19:22 IST BSE
Management ChangeINDO SMC Ltd 544681

INDO SMC Management Change

INDO SMC Limited appointed Sunil Mulchandani & Associates as Secretarial Auditor for a five-year term. The appointment ensures long-term regulatory compliance oversight.

Execution
5 consecutive financial years (F.Y. 2025-26 to F.Y. 2029-30)
19:17 IST BSE
Management ChangeNTPC Ltd NTPC

NTPC Management Change

NTPC Executive Director Shri R Sarangapani has taken pre-mature retirement effective May 19, 2026. This senior management cessation follows his relieved services from the company.

19:15 IST BSE
Board Meeting DatePanjon Ltd PANJON

Panjon Board Meeting Date

Panjon Ltd scheduled a board meeting for May 29, 2026, to approve audited annual financial results. The board will also consider appointing an internal auditor.

19:14 IST NSE
Financial ResultsMankind Pharma Ltd MANKIND

Mankind Pharma Q4 FY26 Results: Net Profit ₹559.4 Cr, Up 31.7% YoY

Mankind Pharma Ltd reported revenue from operations of ₹3,443 Cr (+11.8% YoY) and net profit of ₹559.4 Cr (+31.7% YoY) for Q4 FY26.

Key figure
Net profit ₹559.4 Cr · +31.7% YoY
19:13 IST NSE
Financial ResultsMankind Pharma Ltd MANKIND

Mankind Pharma Financial Results

Mankind Pharma approved its audited FY26 results, reporting consolidated annual revenue of ₹14,277.64 Crore. The Board also cleared a ₹500 Crore investment in its Medicare subsidiary.

19:11 IST BSE
Other AnnouncementClassic Filaments Ltd 540310

Classic Filaments Other Announcement

Classic Filaments Limited declared non-applicability of the Annual Secretarial Compliance Report for FY2026. The company remains exempt due to meeting regulatory capital and net worth thresholds.

19:12 IST BSE
Financial ResultsINDO SMC Ltd 544681

INDO SMC H2 FY26 Results: Net Profit ₹20.9 Cr, Up 344.7% YoY

INDO SMC Ltd reported revenue from operations of ₹197.2 Cr (+186.2% YoY) and net profit of ₹20.9 Cr (+344.7% YoY) for H2 FY26.

Key figure
Net profit ₹20.9 Cr · +344.7% YoY